SAN FRANCISCO (CN) — A Ninth Circuit panel on Thursday upheld the conviction of Joseph Sullivan, the former chief security ...

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (”Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, today provided an update on its two patent ...

Tamil Nadu Chief Minister M K Stalin’s decision to “up the ante” on the north-south divide by constituting a joint action ...

Patna: The jewellery heist worth Rs 25 crore at a Tanishq showroom in Ara town of Bhojpur district created an uproar in the ...

Key Insights Significant control over Aurubis by individual investors implies that the general public has more power ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...

FDA PDUFA review goal date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)Assuming ...

Exelixis' future depends on trial outcomes and patent risks. Find out why EXEL stock is a "Sell" despite cabozantinib's ...

After capturing the program's first-ever playoff win last week, Bishop Stang girls hockey is headed to the Div. 1 state ...

Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib-a differentiated ...